Literature DB >> 18058910

Ghrelin is a novel target of Pax4 in endocrine progenitors of the pancreas and duodenum.

Qian Wang1, Lynda Elghazi, Sophie Martin, Isabelle Martins, R Satish Srinivasan, Xin Geng, Mark Sleeman, Patrick Collombat, Janet Houghton, Beatriz Sosa-Pineda.   

Abstract

Pax4-deficient mice have a severe gastrointestinal endocrine deficiency: they lack most pancreatic cells that produce insulin or somatostatin and various duodenal endocrine cell types. Remarkably, Pax4-deficient mice also have an overabundance of ghrelin-expressing cells in the pancreas and duodenum. Detailed analysis of the Pax4 nullizygous pancreas determined that the mutant islets are largely composed of a distinctive endocrine cell type that expresses ghrelin, glucagon, islet amyloid polypeptide (IAPP), and low levels of Pdx1. Lineage-tracing analysis revealed that most of these unique endocrine cells directly arose from Pax4-deficient progenitors. Previous in vitro work reported that Pax4 is a transcriptional repressor of islet amyloid polypeptide (IAPP) and glucagon. In this study, we expanded those results by showing that Pax4 is also a repressor of gherlin. Together, our data further support the notion that Pax4 activity is necessary to establish appropriate patterns of gene expression in endocrine progenitors of the digestive tract.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18058910     DOI: 10.1002/dvdy.21379

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  28 in total

Review 1.  On the origin of the beta cell.

Authors:  Jennifer M Oliver-Krasinski; Doris A Stoffers
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

2.  PAX4 promotes PDX1-induced differentiation of mesenchymal stem cells into insulin-secreting cells.

Authors:  Lifa Xu; Congjing Xu; Shuping Zhou; Xueke Liu; Jian Wang; Xinkuang Liu; Suping Qian; Yingru Xin; Yi Gao; Yongqiang Zhu; Xiaolong Tang
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

Review 3.  Therapeutic potential of mesenchymal stem cells in treating both types of diabetes mellitus and associated diseases.

Authors:  Vidul Goenka; Tanhai Borkar; Aska Desai; Raunak Kumar Das
Journal:  J Diabetes Metab Disord       Date:  2020-10-17

4.  The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells.

Authors:  Patrick Collombat; Xiaobo Xu; Philippe Ravassard; Beatriz Sosa-Pineda; Sébastien Dussaud; Nils Billestrup; Ole D Madsen; Palle Serup; Harry Heimberg; Ahmed Mansouri
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

5.  Nkx2.2 and Arx genetically interact to regulate pancreatic endocrine cell development and endocrine hormone expression.

Authors:  Teresa L Mastracci; Crystal L Wilcox; Luis Arnes; Casandra Panea; Jeffrey A Golden; Catherine Lee May; Lori Sussel
Journal:  Dev Biol       Date:  2011-08-11       Impact factor: 3.582

Review 6.  Pancreas-specific Cre driver lines and considerations for their prudent use.

Authors:  Mark A Magnuson; Anna B Osipovich
Journal:  Cell Metab       Date:  2013-07-02       Impact factor: 27.287

7.  Nkx2.2 activates the ghrelin promoter in pancreatic islet cells.

Authors:  Jonathon T Hill; Christina S Chao; Keith R Anderson; Fernanda Kaufman; Christopher W Johnson; Lori Sussel
Journal:  Mol Endocrinol       Date:  2009-12-04

Review 8.  Promoting ectopic pancreatic fates: pancreas development and future diabetes therapies.

Authors:  E J Pearl; M E Horb
Journal:  Clin Genet       Date:  2008-09-09       Impact factor: 4.438

9.  Ghrelin-producing epsilon cells in the developing and adult human pancreas.

Authors:  K M Andralojc; A Mercalli; K W Nowak; L Albarello; R Calcagno; L Luzi; E Bonifacio; C Doglioni; L Piemonti
Journal:  Diabetologia       Date:  2008-12-19       Impact factor: 10.122

Review 10.  Pancreas cell fate.

Authors:  Michelle A Guney; Maureen Gannon
Journal:  Birth Defects Res C Embryo Today       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.